HAEGTFT
CAS No. 926018-95-3
HAEGTFT( —— )
Catalog No. M30118 CAS No. 926018-95-3
HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 518 | Get Quote |
|
| 10MG | 794 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameHAEGTFT
-
NoteResearch use only, not for human use.
-
Brief DescriptionHAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
-
DescriptionHAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number926018-95-3
-
Formula Weight761.78
-
Molecular FormulaC33H47N9O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:His-Ala-Glu-Gly-Thr-Phe-Thr
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Retatrutide
Retatrutide (LY3437943) is a triple agonist of the glucagon receptor, glucose-dependent insulinotropic polypeptide receptor, and glucagon-like peptide-1 receptor (GLP-1R), and inhibits GCGR, GIPR, and GLP-1R.Retatrutide can be used to study obesity.
-
GLP-1R modulator C5
GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes.
-
Taspoglutide
Taspoglutide is a glucagon-like peptide-1(GLP-1) agonist for treatment of type 2 diabetes.
Cart
sales@molnova.com